Matthew Kurian: The first KYSCO webinar / cancer, CHI St. Joseph's Health, KYSCO webinar, Matthew Kurian, Neal Dunlap, Nicholas Burnett, OncoDaily, Oncology

Jasmin Hundal: Day 2 at the San Antonio Breast Cancer Symposium was packed with insights / Amy Comander, Arya Roy, cancer, Jasmin Hundal, Matthew Kurian,

Sara Hurvitz, MD, of Fred Hutch Cancer Center, and Neil Iyengar, MD, of Memorial Sloan Kettering Cancer Center, sit down with Chandler Park, MD, FACP, to discuss the latest abstracts in breast cancer ...

Imlunestrant is a next-generation, brain-penetrant, oral selective estrogen-receptor (ER) degrader that delivers continuous ER inhibition, even in cancers with mutations in the gene encoding ERα (E...

PURPOSEClinicopathological factors and the 21-gene Oncotype DX Breast Recurrence Score (RS) test both influence prognosis. Our goal was to develop a new tool, RSClinN+, to individualize recurrence ris...

This cohort study compares the mortality risk associated with vaginal estrogen therapy vs no hormone replacement therapy in 2 cohorts of patients with breast cancer in Scotland and Wales.